Could Botox stop teeth grinding? A teeth-clenching study

Posted 18 Feb, 2018 [ssba]

Botox — formally known as onabotulinum toxin-A — is an injectable drug that can prevent muscles from contracting. The drug is best known for its cosmetic use; it can be delivered to the facial muscles — mainly those between the eyebrows and around the eyes — to temporarily reduce the appearance of frown lines and crow’s feet.

Botox may also be used for a number of medical conditions, including migraine, overactive bladder, and muscle stiffness. Could bruxism be added to the list?

The new study — recently published in the journal Neurology — attempted to answer this question.

Notably, the study included just 22 people with bruxism – not exactly a huge sample. Participants spent a night in a laboratory, where the researchers monitored their teeth grinding and clenching.

The next day, 13 of the subjects were randomized to receive Botox, while the others were given a placebo injection. Injections were administered to the temporal and masseter muscles, which we use for chewing.

Around 4–8 weeks later, subjects were asked to spend another night in the laboratory, and the researchers reassessed their bruxism symptoms.

Please click the link below to read further:

https://www.medicalnewstoday.com/articles/320666.php

At Pain spa Dr. Krishna has been offering the above treatment for a number of years now. Please click the link below to read more about this treatment on our website: 

Botox for TMJ Dysfunction

Have a question? Or would like to book in with us?

Get in Touch

Common Conditions
that we Treat Everyday

View All Conditions

Latest from the Blog

Posted 07 Feb, 2019

Stellate Ganglion Block a Potential Lifesaver in Severe PTSD

Case reports are mounting of immediate, durable, and significant relief of severe refractory symptoms of posttraumatic stress disorder (PTSD), according to an anesthesiologist who has seen the benefits firsthand. Stellate ganglion blockade (SGB) “seems to significantly improve PTSD symptoms as well as significant...
Posted 25 Jan, 2019

CGRP Antagonists: A new era for migraine treatment

Migraine is a common medical condition, affecting as many as 37 million people in the US. It is considered a systemic illness, not just a headache. Recent research has demonstrated that changes may begin to occur in the brain as long as 24 hours before migraine symptoms begin. Many patients have a severe throbbing head...